JATT Acquisition Corp’s Lock-Up Period Set To Expire Tomorrow (NYSE:JATT)

JATT Acquisition’s (NYSE:JATT) lock-up period is set to expire on Wednesday, October 14th. JATT Acquisition had issued 6,000,000 shares in its IPO on April 17th. The total size of the offering was $60,000,000 based on an initial share price of $10.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the end of the lock-up period.

JATT Acquisition Stock Down 0.1%

Shares of NYSE JATT opened at $10.59 on Tuesday. The business has a fifty day simple moving average of $12.02 and a two-hundred day simple moving average of $10.69. JATT Acquisition has a twelve month low of $9.99 and a twelve month high of $23.76.

Institutional Inflows and Outflows

An institutional investor recently bought a new stake in JATT Acquisition stock. Spruce Street Capital LP purchased a new stake in JATT Acquisition Corp (NYSE:JATT) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 160,000 shares of the company’s stock, valued at approximately $1,817,600. Spruce Street Capital LP owned about 1.99% of JATT Acquisition as of its most recent SEC filing. Hedge funds and other institutional investors own 47.97% of the company’s stock.

About JATT Acquisition

JATT Acquisition Corp. was a special purpose acquisition company formed to identify and complete a business combination with a company in the healthcare, biotechnology, pharmaceutical or medical-device sectors. As a blank-check company, it did not operate a commercial business or offer products and services of its own before completing a transaction.

JATT announced a business combination with Zura Bio Limited, a biotechnology company developing medicines for immune-mediated diseases. The transaction was completed in 2023, after which the combined company operated under the Zura Bio name and JATT Acquisition Corp.